A passionate molecular virologist who believe in patient oriented scientific research. Using viruses to understand human existence. Science is for society.
@ahandvanish I mean, is there any good publication which shows the fact that so called early recovered patients also have very high values of those 5 markers you mentioned, even up to 6-12 months post infection.
@ahandvanish Can you refer me to a good paper showing these markers being high for a longer time post COVID infection? We also see them high in patients even up to 12 months after first COVID infection, which argues against the concept of using recovered patients at early stage as control.
@RenzPolster Our core research revolves around PEM and we agree that one cannot understand ME without understanding PEM. But a lot of things happen before ME develops or PEM comes into the equation. Sometimes papers fit into a very specific theme that has a broader implication.
On International ME/CFS Awareness Day, we stand with millions of people living with a disease that has too often been misunderstood, underestimated, and neglected. ME/CFS patients deserve visibility, dignity, and a scientific response equal to the severity of their illness.
@qiru_shi77198 Very interesting. You should try to converge your ideas to our recent findings about natural antibodies. Will be interesting to see what comes out.
Very excited to share our publication in BBI-Health. Many thanks to a 3 year long collaboration between Uni Würzburg, Charité Berlin, UCSD, and RSU, Riga. https://t.co/gH2ThKPAOq
@32Sfc46582 Science done in the last 50 years gives us unimaginable amounts of information, which we are using & interpreting in a new way now. Technology is revolutionizing our field of view but results from past still stands accurate today. We just have to learn how to put them together.
Science around #MECFS is moving faster than ever before. Across the world, serious efforts are accelerating to understand its biology, improve diagnosis, and open paths toward treatment. Please do not lose hope. Real progress is coming, and the future holds promise. #HopeForMECFS
@32Sfc46582 What is in front of you is only a fragment; society is shaped by forces far beyond your field of view. You can easily see divergence, as it shows differences that is easy to see. Divergence can be an illusion; convergence gives hope that unifying facts may lead us to a solution.
@MartinMoltke Please don’t donate! That’s not my aim. We will do research the way it can actually achieve its aim. Donations do help but not at the cost of personal sacrifice for patients.
At PRUSTY Lab, we’re excited to pioneer a shift from static snapshots to dynamic response biology in chronic diseases like ME/CFS and long COVID. The most important signals aren’t always visible at first glance; they reveal themselves only when the system is challenged.
1. Heartbroken to see our Horizon proposal for ME/CFS did not pass the cut-off. Every aspect was positively evaluated and got high appreciation. But some unfair negative comments killed the chances of success. Wonder who evaluates these proposals and if they understand ME at all
Congratulations to those who secured EU funding for ME/CFS research. The field is highly neglected. Hence, success from anyone is appreciated. The first time, we qualified with flying colors, but funds were insufficient. This time, all good but unfair arguments. Maybe next time.
0,5 below the cut-off destroys many hopes. But is it really justified by the evaluation report? Well, I guess no one outside the ME/CFS field really cares.
2. One point was the exclusion of patients based on the current treatment and co-syndromes. The argument given is that a large proportion of ME/CFS patients already meet the exclusion criteria. Don’t you agree that stringent patient selection is a strength rather than a weakness?